Rapid Micro Biosystems, Inc. revenue by segment RPID

Annual Quarterly

Rapid Micro Biosystems, Inc. splits its revenue into 6 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $23.4 million, 70% of the total.

USD in millions. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021
Revenue	35	34	28	23	17	23
Product	25 +31.0% share 72.2%	23 +25.1% share 69.7%	19 +26.5% share 66.8%	15 +33.9% share 65.7%	11 share 64.5%	—
Commercial Non Recurring Revenue	—	—	—	—	—	14 share 59.5%
Services	10 -10.3% share 27.8%	10 +9.0% share 30.3%	9 +20.9% share 33.2%	8 +26.9% share 34.3%	6 -0.8% share 35.5%	6 share 26.4%
Commercial Recurring Revenue	—	—	—	—	—	8 share 33.7%
Non Commercial Revenue	—	—	—	—	—	2 share 6.9%
Non Commercial Non Recurring Revenue	—	—	—	—	—	2 share 6.9%

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Laboratory Analytical Instruments (SIC 3826)
Listed as: RPID (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: Lexington, MA
SEC filer status: Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK: 1380106
Former names: RAPID MICRO BIOSYSTEMS INC (until Jul 15, 2009)

Other Laboratory Analytical Instruments companies

All 25 Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.